Helen Winsor | 05/30/2011
Marc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the use of amorphous pharmaceutical materials to improve necessary drug properties. He sums up the important factors to consider when formulating an amorphous substance. Descamps reflects on whether collaborative projects between academia and pharmaceutical companies represent a new trend in pharmaceutic...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More